Business · 08/09/2021Updated: 10/17/2026 · 1 min read
FDA Launches Pilot Program to Review Novel Excipients for Drug Formulations
Summary
The FDA's Center for Drug Evaluation and Research is launching a pilot program to review novel excipients, aiming to facilitate the development of new excipients that can address challenges faced by both excipient manufacturers and drug developers.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →